» Articles » PMID: 35643073

Galectin-9 Supports Primary T Cell Transendothelial Migration in a Glycan and Integrin Dependent Manner

Overview
Date 2022 Jun 1
PMID 35643073
Authors
Affiliations
Soon will be listed here.
Abstract

Adaptive immunity relies on the efficient recruitment of T cells from the blood into peripheral tissues. However, the current understanding of factor(s) coordinating these events is incomplete. Previous studies on galectin-9 (Gal-9), have proposed a functionally significant role for this lectin in mediating leukocyte adhesion and transmigration. However, very little is known about its function in T cell migration. Here, we have investigated the role of the Gal-9 on the migration behaviour of both human primary CD4 and CD8 T cells. Our data indicate that Gal-9 supports both CD4 and CD8 T cell adhesion and transmigration in a glycan dependent manner, inducing L-selectin shedding and upregulation of LFA-1 and CXCR4 expression. Additionally, when immobilized, Gal-9 promoted capture and firm adhesion of T cells under flow, in a glycan and integrin-dependent manner. Using an in vivo model, dorsal air pouch, we found that Gal-9 deficient mice display impaired leukocyte trafficking, with a reduction in pro-inflammatory cytokines/chemokines generated locally. Furthermore, we also demonstrate that Gal-9 inhibits the chemotactic function of CXCL12 through direct binding. In conclusion, our study characterises, for the first time, the capture, adhesion, and migration behaviour of CD4 and CD8 T cells to immobilised /endothelial presented Gal-9, under static and physiological flow conditions. We also demonstrate the differential binding characteristics of Gal-9 to T cell subtypes, which could be of potential therapeutic significance, particularly in the treatment of inflammatory-based diseases, given Gal-9 ability to promote apoptosis in pathogenic T cell subsets.

Citing Articles

Prediction of Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease Using Circulating Immunomodulatory Proteins.

Li B, Shaikh F, Younes H, Abuhalimeh B, Chin J, Rasheed K Biomedicines. 2025; 12(12.

PMID: 39767748 PMC: 11674036. DOI: 10.3390/biomedicines12122842.


Vascular galectins in tumor angiogenesis and cancer immunity.

Thijssen V Semin Immunopathol. 2024; 46(1-2):3.

PMID: 38990363 PMC: 11239785. DOI: 10.1007/s00281-024-01014-9.


The role of galectins in mediating the adhesion of circulating cells to vascular endothelium.

Souchak J, Mohammed N, Lau L, Dimitroff C Front Immunol. 2024; 15:1395714.

PMID: 38840921 PMC: 11150550. DOI: 10.3389/fimmu.2024.1395714.


Killer instincts: natural killer cells as multifactorial cancer immunotherapy.

Nersesian S, Carter E, Lee S, Westhaver L, Boudreau J Front Immunol. 2023; 14:1269614.

PMID: 38090565 PMC: 10715270. DOI: 10.3389/fimmu.2023.1269614.


Membrane organization by tetraspanins and galectins shapes lymphocyte function.

Cano L, Dunlock V, Schwerdtfeger F, Spriel A Nat Rev Immunol. 2023; 24(3):193-212.

PMID: 37758850 DOI: 10.1038/s41577-023-00935-0.